OrbiMed Capital GP IV LLC, 10% Owner at Audentes Therapeutics, Inc. (BOLD), sold 5,000 shares at $22.35 ($112K) on 2017-09-07, disclosed to the SEC on 2017-09-11.
Open-market sale of $112k BOLD by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |
| OTIC | SELL | 2015-11-19 | $4.0M | — | Filing → |